Abstract Drug resistance is vital for the poor prognosis of acute myeloid leukemia (AML) patients. but the underlying mechanism remains poorly understood. Given the unique microenvironment of bone marrow. we reasoned that drug resistance of AML might rely on distinct metabolic processes. https://www.alarecre.com/